trial · primary record
Abiraterone Acetate
Prostatic Neoplasms
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 57 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Area Under the Plasma Concentration-time Curve From Time Zero to Time 24 Hours (AUC [0-24]) of abiraterone |
| Registry ID | NCT02123758 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:40.274Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02123758
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Abiraterone Acetate · approval
- Abiraterone Acetate · compound